2009
DOI: 10.1016/j.ejvs.2008.10.012
|View full text |Cite
|
Sign up to set email alerts
|

Preclinical Development of Tissue-Engineered Vein Valves and Venous Substitutes using Re-Endothelialised Human Vein Matrix

Abstract: Treatment with SD and DNase enables complete decellularisation of human valve containing veins whereas 3D matrix components such as collagen and elastin remain preserved. The lumen of the scaffold including the valves can be successfully re-seeded with a human EC monolayer in a 3D bioreactor. There is substantial evidence that hABS and not FCS is essential for the completion of cell-matrix contacts in human veins.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0
1

Year Published

2010
2010
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(21 citation statements)
references
References 34 publications
0
20
0
1
Order By: Relevance
“…In the past, decellularized blood vessels have been studied for their potential use as vascular grafts for small diameter arteries (Antonova et al, 2008;Borschel et al, 2005;Jo et al, 2007;Schaner et al, 2004;Gui and Niklason, 2014). They consist of a natural extracellular matrix, have very low immunogenicity and can be reseeded with various cells of choice and for any period of time (Teebken et al, 2009;Amiel et al, 2006). Though numerous decellularization protocols exist, there was no satisfying procedure for modeling the in vivo situation due to significantly altered mechanical characteristics compared to native vessels (Roy et al, 2005;McFetridge et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the past, decellularized blood vessels have been studied for their potential use as vascular grafts for small diameter arteries (Antonova et al, 2008;Borschel et al, 2005;Jo et al, 2007;Schaner et al, 2004;Gui and Niklason, 2014). They consist of a natural extracellular matrix, have very low immunogenicity and can be reseeded with various cells of choice and for any period of time (Teebken et al, 2009;Amiel et al, 2006). Though numerous decellularization protocols exist, there was no satisfying procedure for modeling the in vivo situation due to significantly altered mechanical characteristics compared to native vessels (Roy et al, 2005;McFetridge et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…Despite the existence of various decellularization protocols, e.g., for bladder (Bolland et al, 2007) and heart valves (Rieder et al, 2004;Teebken et al, 2009), the efficiency of a method depends mainly on the tissue type. Previously described protocols (Dahl et al, 2003;Williams et al, 2009) did not work properly for arterial vessels.…”
Section: A B Cmentioning
confidence: 99%
“…Venous endothelial cells or bone marrow-derived endothelial cells have demonstrated their affinity to the decellularized venous surface [Teebken et al, 2009;Shen et al, 2016]. Kuna et al [2015] introduced a model consisting of decellularized venous valves incubated with whole blood followed by selective perfusion with endothelial growth medium.…”
Section: Discussionmentioning
confidence: 99%
“…133,134 While these systems provide insight into cellular behavior in these more complex conditions, they are less conducive to vessel fabrication in vitro . Still more complex bioreactors incorporate perfused, harvested vessels or vessel constructs; engineered blood vessels mimics such as decellularized cadaver vessels, 135 porcine arteries, 136 and human saphenous veins 137 ; peripheral blood–derived blood vessel mimics 138,139 ; and synthetic cylindrical polymer scaffolds 140 to generate vessels as small as 4 mm in diameter.…”
Section: Microvascular Assemblymentioning
confidence: 99%